Puma Biotechnology (PBYI) PT Lowered to $24 at Goldman Sachs
Tweet
Share
E-mail
Get Alerts PBYI Hot Sheet
Price: $8.71 -2.13%
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on Puma Biotechnology (NASDAQ: PBYI) to $24.00 (from $29.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$440 at Macquarie
- Birkenstock Holding plc (BIRK) PT Raised to $44 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
